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CONSENSUS STATEMENT
Statement of the Third International Exercise-Associated
Hyponatremia Consensus Development Conference,
Carlsbad, California, 2015
Tamara Hew-Butler, DPM, PhD,* Mitchell H. Rosner, MD,† Sandra Fowkes-Godek, PhD, ATC,‡
Jonathan P. Dugas, PhD,§ Martin D. Hoffman, MD,¶ Douglas P. Lewis, MD,k
Ronald J. Maughan, PhD,** Kevin C. Miller, PhD, ATC,†† Scott J. Montain, PhD,‡‡
Nancy J. Rehrer, PhD,§§ William O. Roberts, MD, MSc,¶¶ Ian R. Rogers, MBBS,kk
Arthur J. Siegel, MD,*** Kristin J. Stuempfle, PhD,††† James M. Winger, MD,‡‡‡
and Joseph G. Verbalis, MD§§§
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(Clin J Sport Med 2015;25:303–320)
INTRODUCTION
The third International Exercise-Associated Hyponatre-
mia (EAH) Consensus Development Conference convened in
Carlsbad, California in February 2015 with a panel of 17
international experts. The delegates represented 4 countries and
9 medical and scientific sub-specialties pertaining to athletic
training, exercise physiology, sports medicine, water/sodium
metabolism, and body fluid homeostasis. The primary goal of
the panel was to review the existing data on EAH and update
the 2008 Consensus Statement.1 This document serves to
replace the second International EAH Consensus Development
Conference Statement and launch an educational campaign
designed to address the morbidity and mortality associated
with a preventable and treatable fluid imbalance.
The following statement is a summary of the data
synthesized by the 2015 EAH Consensus Panel and represents
an evolution of the most current knowledge on EAH. This
document will summarize the most current information on the
prevalence, etiology, diagnosis, treatment and prevention of
EAH for medical personnel, athletes, athletic trainers, and the
greater public. The EAH Consensus Panel strove to clearly
articulate what we agreed upon, did not agree upon, and did not
know, including minority viewpoints that were supported by
clinical experience and experimental data. Further updates will
be necessary to both: (1) remain current with our understanding
and (2) critically assess the effectiveness of our present
recommendations. Suggestions for future research and educa-
tional strategies to reduce the incidence and prevalence of EAH
are provided at the end of the document as well as areas of
controversy that remain in this topic.
CONSENSUS METHODOLOGY
The third International Exercise-Associated Hyponatre-
mia Consensus Development Conference utilized National
Institutes of Health guidelines, amended for a more holistic
approach to fit the needs of both the group and the topic.
Twenty-two individuals (17 accepted) were invited to partic-
ipate in the consensus conference who: (1) have made
scientific and/or clinical contributions to the topic of water
and sodium homeostasis and/or hyponatremia and (2) repre-
sented a specific group (eg, nephrology, endurance medicine,
etc.) or had unique topical expertise (eg, cystic fibrosis,
muscle cramps, fluid balance, etc.). The present document is
intended to serve as the scientific record of the conference
with intent to widely disseminate this information to achieve
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maximum impact on both current health care practice and
future medical research.
The methodology governing the conduct of this con-
sensus development conference is summarized below:
1. A broad based expert panel was assembled. Panel members
included researchers and clinicians in endocrinology (J.G.V.),
nephrology (M.H.R.), emergency medicine (I.R.R.), family
medicine (W.O.R., J.M.W., D.P.L.), internal medicine
(A.J.S.), physical medicine and rehabilitation (M.D.H.),
sports medicine (W.O.R., J.M.W., D.P.L.), athletic train-
ing (S.F.-G., K.C.M.) and exercise physiology (J.P.D.,
S.F.-G., T.H.-B., M.D.H., R.J.M., S.J.M., N.J.R., K.J.S.).
2. These experts presented data on EAH in a day long public
session, followed by open question/answer and discussion
periods with the audience. The panel members met the
following day in a closed session to prepare the consensus
statement.
3. Workgroups were created 3 months prior to the February
2015 meeting to update the following EAH target areas:
epidemiology, etiology and pathophysiology, diagnosis,
treatment, and prevention. Each workgroup was asked to
present updated drafts for discussion during the closed
session.
4. A systematic, comprehensive and updated literature review
was shared by the panel members prior to the February
2015 meeting, using a cloud storage service that was orga-
nized into workgroup categories (epidemiology, etiology
and pathophysiology, diagnosis, treatment and preven-
tion). All panel members had unlimited access to the cloud
storage service and could add digital versions of published
manuscripts to the EAH manuscript section at any time.
The panel chairperson (MHR) was responsible for
monitoring the progress of each work group, directing the
closed session and guiding the panel’s deliberations. Using
the previous 2 EAH consensus statements as a starting point,
each work-group was asked to: (1) incorporate new data into
each assigned section and (2) update any outdated informa-
tion. All recommendations were graded based on clinical
strength, using the grading scale described by the American
College of Chest Physicians (Table 1).2 Particular emphasis
was placed on creating more generalized recommendations so
as to prevent and treat EAH across a wider variety of athletic
events, rather than the endurance sports focus of the 2 prior
EAH Consensus Statements.
Sponsorship
The travel (except R.J.M. and I.R.R., who supported
their own travel), hotel and meal expenses for the participants
were funded by CrossFit, Inc (Solana Beach, CA). The open
conference was also sponsored by CrossFit, Inc. However, no
members from CrossFit, Inc participated in any of the closed
discussions or contributed to the development of the consen-
sus guidelines. Furthermore, no members from CrossFit, Inc
had access to the consensus document prior to publication.
RESULTS AND DISCUSSION
Definition
EAH is used to describe hyponatremia occurring during
or up to 24 hours after physical activity. It is defined by
a serum, plasma or blood sodium concentration ([Na+]) below
the normal reference range of the laboratory performing the
test. For most laboratories, this is a [Na+] less than
135 mmol/L.1 The main determinants of the serum [Na+] are
the total content of exchangeable body sodium and potassium
relative to total body water and thus hyponatremia can result
TABLE 1. American College of Chest Physicians Classification Scheme for Grading Evidence and Recommendations Utilized in
This Statement2
Grade Description Benefits vs Risks and Burdens
Methodological Quality of
Supporting Evidence
1A Strong recommendation, high-quality
evidence
Benefits clearly outweigh risks and
burdens or vice versa
RCTs without important limitations
or overwhelming evidence from
observational studies
1B Strong recommendation, moderate-
quality evidence
Benefits clearly outweigh risks and
burdens or vice versa
RCTs with important limitations or
exceptionally strong evidence from
observational studies
1C Strong recommendation, low-quality
or very low quality evidence
Benefits clearly outweigh risks and
burdens or vice versa
Observational studies or case series
2A Weak recommendation, high-quality
evidence
Benefits closely balanced with risks
and burdens
RCTs without important limitations
or overwhelming evidence from
observational studies
2B Weak recommendation, moderate-
quality evidence
Benefits closely balanced with risks
and burdens
RCTs with important limitations or
exceptionally strong evidence from
observational studies
2C Weak recommendation, low-quality
or very low quality evidence
Uncertainty in the estimates of
benefits, risks and burden; benefits,
risk and burden may be closely
balanced
Observational studies or case series
RCT, randomized controlled trial.
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from loss of solutes (sodium, potassium), a relative excess of
total body water or a combination of both.3,4 However, in
most clinical scenarios, the driving force for the develop-
ment of hyponatremia is a relative excess of total body
water.5,6 The symptoms associated with EAH depend on
both the magnitude of the serum sodium decrease from base-
line level along with the rate at which this decrease occurs.
Symptomatic EAH can occur if the rate of fall approaches
7% to 10% within 24 hours.7 Thus, more severe degrees of
hyponatremia (typically ,125 mmol/L) as well as more
modest serum sodium values (in the range of 125-130
mmol/L), that develop over a short period of time, can both
be associated with signs and symptoms.8
Epidemiology
The vast majority of recreationally active individuals
begin endurance races with a blood [Na+] above 135
mmol/L. Based on data pooled from 27 separate studies,
encompassing 2262 participants with a verifiable pre-race
blood [Na+] measurement, only 0.8% (19/2262) presented
with hyponatremia prior to race start.9–35 These pooled data
represent blood [Na+] measurements collected in 7 countries
and between 5 minutes to 72 hours pre-competition. This
0.8% also includes 16 questionable below-normal [Na+] val-
ues possibly confounded by fingerstick hemolysis29 and/or
outdated techniques.25 Thus, baseline (pre-event) hyponatre-
mia in recreational exercisers appears to fall within the ex-
pected range for a normal population distribution (1%-2%),
and at a frequency well below what has been observed in
individuals presenting for non-hyponatremia related clinical
treatment situations36 or in hospitalized patients.37 We
thereby believe that EAH largely develops during or imme-
diately following exercise.
Exercise-associated hyponatremia can present in 2
forms: asymptomatic or symptomatic. Asymptomatic ath-
letes with [Na+] ,135 mmol/L have largely been detected
by blood samples taken post-exercise from athletes partici-
pating in research protocols or obtained for reasons other
than suspicion of EAH. Athletes with the symptomatic form
of EAH can present with mild, non-specific symptoms
(eg, lightheadedness, nausea) but typically present with
headache, vomiting, and/or altered mental status (eg, confu-
sion, seizure) resulting from cerebral edema (termed
exercise-associated hyponatremic encephalopathy or EAHE)
that may38–48 or may not49–52 be associated with non-
cardiogenic pulmonary edema. EAHE is a life-threatening
condition that has been observed across a wide variety of
activities (Table 2). The incidence of asymptomatic and
symptomatic cases of EAH varies widely with regard to type
and duration of activity, location of the event, characteristics
of the participants (see risk factors) and heat or cold stress
during the event.
Epidemiology of Asymptomatic EAH
The reported incidence of asymptomatic EAH has
ranged from 0%30,53 to 51%54 immediately post-race. In
a study of an ultramarathon, 67% of the participants were
hyponatremic (asymptomatic) at some point during the race,
but only 27% finished the with serum [Na+] ,135 mmol/L
(40% self-corrected prior to finishing the event).11 The high-
est reported incidence of asymptomatic hyponatremia post-
race has been consistently noted in 161-km ultramarathons,
in which the reported incidence of EAH has ranged between
5% and 51%.18,54–56 The incidence of asymptomatic EAH in
Ironman triathlons in different environments has been re-
ported to range from negligible10 to as high as 18%57 and
25%.19 In studies on endurance cyclists the incidence of
asymptomatic EAH has ranged from 0% in a 720-km race30
to 12% in a 109-km race.15 In a 26.4-km swim, 17% of
swimmers developed asymptomatic hyponatremia.32 The re-
ported incidences at the standard marathon distance run
(42.2 km) have ranged from 0%53 to 12% to 13% of race
finishers.28,58 Additionally, asymptomatic hyponatremia was
observed in 33% of premier league UK rugby players fol-
lowing an 80 minutes rugby competition59 and 70% of elite
rowers during a 28-day training camp.60
Epidemiology of Symptomatic EAH
Symptomatic EAH is rare and occurs with considerably
less frequency than asymptomatic EAH, but complications
associated with EAH have led to at least 14 athlete related
deaths since 1981.28,38,47,50,61–69 Symptomatic EAH generally
occurs as an isolated case or in small clusters during or fol-
lowing endurance events with participants reporting to the
race medical facilities or to hospital emergency departments
within 24 hours after participation. In general, participants
seek treatment for a constellation of symptoms ranging from
feeling unwell to convulsions. Clusters of cases have occurred
in military training exercises, marathons, Ironman triathlons
and ultramarathons. The incidence of symptomatic EAH has
been reported to be as high as 23%57 and 38%70 of athletes
seeking medical care in an Ironman Triathlon and an ultra-
marathon, respectively, but most endurance events report no
cases of symptomatic EAH, especially at the marathon dis-
tance and below.
Two studies have examined large compilations of data
to help define the incidence of symptomatic and asymptom-
atic EAH.55,71 In the first study of 2135 athletes from 8 endur-
ance events ranging in length from 42.2 to 161 km,71 the
incidence of symptomatic EAH was 1% (compared to 6%
with asymptomatic EAH) among study participants. In the
TABLE 2. Activities in Which Symptomatic EAH Has Been
Reported. Those Activities in Which Known Deaths Have
Occurred Are Noted With an Asterik (*)
Documentation of Symptomatic EAH
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second study of 669 161-km ultramarathon runners,55,72 only
one case (0.1% among study participants) of symptomatic
EAH presented during the 5-year sampling period (compared
to 13% with asymptomatic EAH), but considering the total
number of race participants over this time period, the actual
incidence of symptomatic EAH was approximately 0.06%.
Symptomatic EAH has also been reported in hikers73–75
and military personnel.75–77 Symptomatic EAH accounted for
16% of Grand Canyon hikers seeking medical care for
exercise-associated collapse or exhaustion from May 31,
1993 through September 31, 1993 providing an estimated
incidence rate between 2 and 4 per 100,000 persons.73,78 Fur-
thermore, suspected hyponatremia was found to account for
19% of non-fatal suspected heat-related incidents in the
Grand Canyon National Park from April through September
during 2004 through 2009 hiking seasons.74 In the US active
duty military, the annual incidence rate of hyponatremia from
1999 through 2012 has ranged from ;4 to 13 cases per
100,000 person-years (averaged 6.7 cases per 100 000
person-years).77 However, this incidence is probably inflated
as the data were derived from a medical coded database that
does not have a specific designation for EAH and likely in-
cludes hyponatremia from both exercise and non-exercise
related conditions.
Alarmingly, symptomatic EAH is now being reported
in a more diverse set of sporting activities. For instance,
symptomatic EAH has been reported in shorter distance
endurance competitions, such as a half marathon79 with slower
finishers completing the distance in 2 to 3 hours and a sprint
triathlon with slower finishers taking approximately 2 hours to
complete.80 In addition, EAH has been reported in US pro-
fessional and college American rules football players40,41 and
has led to the deaths of 3 US high school football players
between 2008 and 2014.63,64,69 Symptomatic hyponatremia
has also been reported in a 48 year old lawn bowler who
was heterozygous for the Delta F508 cystic fibrosis (CF) muta-
tion, although it is unclear if complete genetic analysis for all
possible CF mutations was performed,81 a 34 year old woman
following a Bikram Yoga session82 and in a 39 year old woman
following a 2 hour workout including tennis and weightlift-
ing.83 Cases of symptomatic EAH have also been induced in 2
separate laboratory studies involving low intensity exercise
conducted in high ambient temperatures.84,85 Deaths from
symptomatic EAH have occurred in a 25 year old male police
officer participating in a 19-km bicycle training ride68 and at
least partially contributed to a case of fraternity hazing
involving a male pledge performing calisthenics.67 It is likely
that other cases of symptomatic hyponatremia have either not
been recognized or reported.
Risk Factors
The major risk factors for developing EAH are listed
in Table 3. The single most important risk factor is sus-
tained, excessive fluid (water, sports drinks or other hypo-
tonic fluids) intake in volumes greater than loss through
sweat, respiratory and renal water excretion so that a positive
fluid balance accrues over time.86,87 Almost all cases of
symptomatic EAH have occurred in individuals who have
gained or maintained weight during activities in which some
weight loss would represent fluid balance and euhydra-
tion.71,72 Body weight losses of ,0.75 kg after a standard
marathon35 and ,1% after an 80 minutes rugby match59
have been associated with asymptomatic EAH. All sports
beverages are hypotonic to plasma (typical sodium content
in sports drinks are approximately 10-38 mmol/L88); thus the
magnitude of excessive fluid volume ingestion will over-
whelm any protective effect of the beverages’ sodium con-
tent on maintaining serum [Na+].89,90
From a practical standpoint, it is the smaller individ-
uals and those who participate at a slower pace and drink
more than sweat losses that are more likely to develop
EAH. Although the incidence of women experiencing EAH
is greater than that of men,38,58,61 adjusted for BMI and
racing time, the apparent sex difference is not statistically
significant.58
Nonsteroidal anti-inflammatory drugs (NSAIDs) have
been implicated as a risk factor in the development of
EAH38,91,92 presumably by potentiating the water retention
effects of arginine vasopressin (AVP) at the level of the kid-
ney collecting duct.93,94 However, data are conflicting,26,58,61
and further investigation is necessary to determine whether
NSAID usage—with respect to both classification and
dosage—is a risk factor for the development of EAH. The
possible pathophysiological contributions of intrinsic renal
disease95 and low solute diets96–98 on water retention, high
sweat sodium concentrations99 in extreme environments,
and the potentiation of thirst by non-osmotic stimuli during
exercise72,100–103 warrant further investigation as secondary
risk factors for EAH. Whether common medications that
are associated with hyponatremia and the syndrome of inap-
propriate anti-diuretic hormone secretion (SIADH) in the gen-
eral population, such as selective serotonin reuptake
inhibitors, can potentiate the development of EAH is not
known and warrants further investigation.104
There is a paucity of evidence suggesting that those
developing symptomatic EAH have either been a “salty
sweater”99,105 or a heterozygous carrier of the cystic fibrosis
genotype.106 Athletes with homozygous CF, however, are at
risk for developing hyponatremia as demonstrated by
numerous instances when an individual is diagnosed with
CF after the development of hyponatremia during prolonged
physical exertion105,107 or prolonged exposure to high ambi-
ent temperatures.108–110 As individuals with CF experience
a longer lifespan (median predicted survival age in 2012 was
41.1 years111) and are encouraged to consider exercise as
TABLE 3. Risk Factors for the Development of Asymptomatic
and Symptomatic EAH1
Risk Factors for EAH
Overdrinking water, sports drinks, and other hypotonic beverages
Weight gain during exercise
Exercise duration .4 h
Event inexperience or inadequate training
Slow running or performance pace
High or low body mass index (BMI)
Readily available fluids
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one of their therapies,112 this population may be at increased
risk for EAH due to the combination of high sweat fluid and
sweat [Na+] loss.
Etiology and Pathophysiology of EAH
The predominant pathophysiology of EAH, and of most
serious medical concern, is dilutional hyponatremia caused by
sustained overdrinking and AVP induced impaired water
clearance, which overwhelms the ability of the kidney to
excrete the excess water load. Dilutional hyponatremia is the
primary pathophysiological variant of clinically symptomatic
EAH and largely (if not exclusively) associated with all
reported cases of morbidity and mortality that are listed in
Table 2. Dilutional EAH is an acute onset form of hypona-
tremia, which is now occurring in non-endurance sports, with
3 deaths, recently reported amongst the approximately 7.5
million American high school football player-years from
2008 through the 2014 seasons.63,64,69 These football players
were encouraged to ingest copious volumes of hypotonic
fluids and sports drinks to prevent or relieve exercise-
associated muscle cramps (EAMC),63,64,69 in the belief that
EAMC was caused by dehydration and electrolyte imbal-
ance.113 However, experimental114,115 and observational116,117
studies speculate that EAMC may reflect neurological
changes due to fatigue rather than uncompensated water
and sodium losses incurred during exercise in some cases.
Muscle cramping and tremor have also been associated with
overdrinking and hyponatremia in athletes,82,100,118,119 clinical
populations,120 and animals.121
Symptoms associated with EAH are due to osmotically-
induced shifts of water into the intracellular compartment. In
the confined space of the cranium these shifts of water into the
central nervous system (CNS) tissues lead to cellular edema
and pathological increases in intracranial pressure. Acutely,
this may manifest in symptoms previously described and in
the extreme may lead to brain stem herniation and death.
Etiology of Euvolemic/Hypervolemic EAH
Total body water expansion relative to the
amount of total body exchangeable sodium is the main
pathogenic cause of asymptomatic and symptomatic
EAH.34,41,45,52,57,58,61,71,73,75,76,84,119,122–126 Dilutional EAH
can be euvolemic (total body water expansion without changes
in total exchangeable sodium) or hypervolemic (total body
water expansion above concomitant increases in total
exchangeable sodium). The primary etiologic factor in dilu-
tional hyponatremia is consumption of fluids (water, sports
drinks or other hypotonic fluids) in excess of total body fluid
losses, which includes the sum of insensible (cutaneous, respi-
ratory, and gastrointestinal),127,128 sweat and renal (urine) fluid
losses.34,45,52,57,58,61,73,75,76,84,119,122–125
Hyponatremia caused solely by the overconsumption of
fluids, above known maximal urine excretory rates of 800 to
1000 mL/,129 has been demonstrated at rest in athletes with
and without a history of EAH.34,86,87 Although some cases of
EAH may be due to pure water intoxication from overcon-
sumption of fluids, non-osmotic AVP secretion is a key con-
tributing factor in most athlete-related symptomatic cases.5,19
Known stimuli to AVP secretion that are commonly
associated with exercise include: nausea/vomiting130;
interleukin-6 release11; plasma volume contraction13; hypo-
glycemia131; elevated body temperature132; and/or other hor-
monal mediators.16 Even small increases in circulating AVP
levels can markedly reduce renal water excretion well below
maximal levels,133 resulting in retained body water not only
when drinking rates do not exceed those necessary to prevent
excessive dehydration, but also when drinking rates are well
in excess of fluid replacement need.49,134
SUMMARY STATEMENT
The primary etiology and pathophysiological mecha-
nism underlying EAH—and all known fatalities—is the over-
consumption of hypotonic fluids relative to exchangeable
sodium in likely combination with non-osmotic AVP secre-
tion (Grade 1A).
Etiology of Hypovolemic EAH
There is persisting debate as to the relative contribution
of under-replaced sodium losses to the lowered sodium
concentrations observed in EAH. While in clinical medicine,
electrolyte depletion without expansion of total body water
or hypovolemic hyponatremia is well described,5,6,135–138 in
EAH this variant has been more difficult to define and is
much less likely to be encountered except in extreme events
usually over prolonged periods (such as ultra-marathons)139
or hot Ironman distance triathlons.19,20 The data regarding
sodium losses during exercise (as measured during recovery)
and their potential contribution to the development of symp-
tomatic hyponatremia in longer and hotter races139 have been
consolidated in Table 4 against data collected from relatively
shorter and cooler races123,140,141 where fluid overload hypo-
natremia has been verified. From the standpoint of the clin-
ical literature, hypovolemic hyponatremia reflects a loss of
total body exchangeable sodium that manifests as volume
depletion.5,6,135,142,143 Hypovolemic EAH would be predicted89
to occur in athletes exercising for longer periods of time (such
as 161 km ultramarathons; .20 hours),11,54–56 and/or in
hotter11,19,20,55,108,109 environments and/or with higher sweat
sodium losses.99,101 Clinical confirmation of the hypovolemic
form of hyponatremia is supported by a spot urine sodium
concentration (U[Na+]) below 30 mmol/L136,137,144 in conjunc-
tion with a serum or plasma [Na+] below 135 mmol/L. A spot
U[Na+] ,30 mmol/L is 100% specific and 80% sensitive for
predicting a sustained increase (.5 mmol/L) in serum [Na+]
following isotonic saline administration136 in clinical patients.
Elevated blood urea nitrogen levels (.20 mg/dL)136,139 and
weight loss19,20,55 may also suggest volume depletion as
a pathogenic contributor to EAH. However, these biochem-
ical tests are not always available at the point of care and
thus clinical assessment (vital signs, weight change, and
physical examination) may be the only indication of volume
depletion.
SUMMARY STATEMENT
Under-replaced sodium losses contribute to serum
[Na+] independent of distance (Grade 1A). However, there
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is paucity of data supporting sodium loss as the primary
mechanism of symptomatic EAH even in those who exercise
for prolonged periods of time and in warm weather (Grade
2C). In these cases, relative over-drinking of hypotonic fluids
with sustained non-osmotic AVP secretion is likely involved
in the development of symptomatic EAH.
The Role of Thirst
Since drinking fluid volume above sweat and urinary
losses during and after activity is the main pathophysiolog-
ical mechanism underlying asymptomatic, symptomatic and
fatal cases of EAH, prevention is dependent on drinking
less. Thirst should provide adequate stimulus for preventing
excess dehydration and markedly reduce the risk of devel-
oping EAH in all sports. Physiologically-driven thirst has
been defined as a “generalized, deep seated feeling of desire
for water”145 and is an evolutionarily conserved, finely
tuned, regulatory mechanism serving to protect both plasma
osmolality and circulating plasma volume.146 Osmoreceptors
located within the circumventricular organs of the brain
(highly vascularized structures located around the third
and fourth ventricles and characterized by the lack of
a blood–brain barrier that are points of communication
between the blood, the brain parenchyma, and the cerebral
spinal fluid) and baroreceptors located within the aortic arch,
carotid sinus and great veins provide “real-time” neural
input to higher centers of the brain which continuously
and simultaneously coordinate the regulation of both thirst
and AVP secretion. Thus, there are physiological sensing
mechanisms in place to prompt when to drink and therefore
guard against excessive dehydration. Earlier published rec-
ommendations to begin drinking before thirst was largely
meant for situations where sweating rates were high, above
maximal rates of gastric emptying, and dehydration would
rapidly accrue over time. Unfortunately, this advice has fos-
tered the misconception that thirst is a poor guide to fluid
replacement and has facilitated inadvertent overdrinking and
pathological dilutional EAH.
Clinical Classification and Diagnosis of EAH
The diagnosis of EAH is made when the blood, serum
or plasma [Na+] is below the normal reference range of the
laboratory performing the test (typically ,135 mmol/L) and
is associated with typical clinical constellation of symptoms
and signs. In our collective experience, EAH is best classified
by clinical severity (symptoms) and not the absolute numer-
ical [Na+] value to best guide treatment strategies.
Characteristics of Asymptomatic EAH
Asymptomatic EAH represents a biochemical finding,
diagnosed by blood electrolyte testing for research or
unrelated metabolic screening purposes.10,15,18,19,28,30,32,53–59
This group of subjects presents without any discernable
symptoms or may have mild, generalized and transient
complaints commonly experienced by other participants
who do not typically seek medical care following exercise.
In normally distributed populations, up to 5% of all athletes
tested would fall outside of the normal range for [Na+],
with half of those (2.5%) falling in the range of asymptom-
atic EAH values.
Characteristics of Mild EAH
Mildly symptomatic EAH typically presents with non-
specific signs and symptoms without clear signs of encepha-
lopathy (Table 5). Athletes with mild EAH may have normal
vital signs, may not have any orthostatic hypotension, and the
symptoms do not resolve after placing athletes in the Trende-
lenburg position147 as would be expected with exercise
TABLE 4. Comparisons of Sodium and fluid Balance Measured During the Recovery Period After Exercise Demonstrating Race
Characteristics and Biochemical Differences Between Fluid Overload Hyponatremia (Irving et al,123 Speedy et al,140 and Speedy
et al141) Versus Suspected Hypovolemic Hyponatremia (Owen et al139)
Variable Irving et al123 Speedy et al140 Speedy et al (2 cases)141 Owen et al139
EAH subjects (classification)* 8 (symptomatic) 7 (symptomatic) 2 (asymptomatic) 26 (asymptomatic)
Peak race temperature (8C) NR 21 21 33
Mean exercise duration (h) ,11 (mean NR) 12 13/12 (case 1/case 2) 22
Monitored recovery time (h) 16 11.6 11.7/13 1
Presenting U[Na+] (mmol/L) NR 17† (41 controls)* NR 15 pre-trial (22.3 post-trial)
Presenting BUN (mg/dL) 15.5 pre-trial (9.8 post-trial) NR NR 31 (pre and post-trial)
Body sodium retained
(mean value)‡
48% 284 mmol (0 mmol controls)* 34%/0% 96%
Excess fluid excreted (mL)§ +2953 +1670 (2441 controls)* +1500/+2500 +20
Presenting serum [Na+]
(mean 6 SD) (mmol/L)
122 6 2 127 6 4 131/130 131 6 3
Body weight change (post-race 2
pre-race) (%)
NR NR +0.9/+2.5 22.4 6 3.1
*EAH data compared with control group of normonatremic triathletes partaking in the same event.
†All but one of these 7 athletes with EAH was released from the hospital with hyponatremia.
‡This represents the total amount of sodium retained by the body and expressed as a percentage of the total amount of sodium that was administered during the monitored recovery
period (sodium deficit/sodium given). In Speedy et al 2000,140 this was expressed as a positive or negative amount (mmol) of sodium administered so that a negative value reflected the
amount of sodium retained by the body (UNa+ output minus Na+ input).
§This represents the amount of fluid excreted (urine volume) during the recovery period compared with the amount of fluid that was administered during the recovery period.
NR, not reported in the manuscript.
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associated postural hypotension.148 The clinical symptoms of
mild symptomatic EAH are not specific or sensitive, but
should raise the index of suspicion for EAH and necessitate
a low threshold for [Na+] measurement, as athletes can rap-
idly progress from mild symptoms to severe and life-
threatening EAHE (Table 5).
EAH must be differentiated from other causes of
collapse that may present with similar signs and symptoms
including exertional heat illness,73 acute mountain sickness,39
hypernatremia,149,150 and exercise associated postural hypo-
tension.148 It is important for medical staff to perform a rapid
history and physical examination to help determine the eti-
ology of these nonspecific symptoms. However, any clini-
cal suspicion of EAH should lead to prompt measurement
of [Na+], if possible. It is common for athletes with EAH to
maintain or gain weight during exercise.58,71,72 However,
EAH in the presence of weight loss has been documented
in ultra-endurance races in the heat.19,20,55,59 Thus, the
presence of weight loss does not necessarily exclude
EAH. Weight gain or weight maintenance associated with
any symptoms listed in Table 5 is an indication to measure
the athlete’s [Na+] in order to confirm or exclude the
diagnosis of EAH or to consider empiric treatment if
on-site [Na+] cannot be measured, such as in remote
settings.72,118,151
Characteristics of Severe EAH (EAHE)
Severe symptomatic EAH is characterized by neuro-
logical signs and symptoms due to cerebral edema that
occur when water flows along the osmotic gradient from the
extracellular fluid into the intracellular compartment
(Table 3).38–52,152 Severe symptomatic EAH may38–48 or
may not49–52 be accompanied by the respiratory distress of
CNS-triggered non-cardiogenic pulmonary edema (Table 5).
EAHE is a life threatening condition that requires urgent
intervention and should be evaluated with an immediate
[Na+] measurement if available.
SUMMARY STATEMENT
EAH can present with a wide range of symptoms
ranging from nonspecific mild complaints to severe en-
cephalopathy. The severity of symptoms and not the
absolute value of the [Na+] should guide the choice of
therapy (Grade 1A). Rapid determination of [Na+] is criti-
cal in confirming clinical suspicion but may not always be
available.
Treatment of EAH
Any athlete exhibiting signs or symptoms consistent
with acute hyponatremia (Table 5) should be screened for
EAH. The capacity for onsite [Na+] analysis is optimal for
management of EAH and is recommended for any large-
scale endurance event. However, this capability is not
always practical or possible (eg, small or remote
events).118,151 Treatment should be based on the degree of
neurological impairment, not simply the [Na+] level5,6; as
brain edema is dependent upon both the magnitude and rate
of fall of [Na+] not just the lowest level reached, as stated
previously. The following treatment protocols are recom-
mended for EAH and EAHE based on either [Na+] measure-
ment and clinic assessment or clinical assessment alone if
[Na+] measurement is not available.
Onsite Treatment of Asymptomatic EAH Found Via
[Na+] Measurement
Asymptomatic hyponatremia is not normally detected
unless an athlete has blood electrolyte concentrations tested
for some other reason.10,15,18,19,28,30,32,53–59 In athletes with
this incidental biochemical diagnosis, oral or intravenous
hypotonic fluid intake should be restricted until the onset
of urination (which suggest that AVP levels have fallen and
that the urine is likely dilute) to reduce the risk of further
decreasing [Na+] with continued AVP-mediated water
retention.5,6,120 Furthermore, isotonic intravenous fluids
should be administered with great caution or withheld until
urination as, in the setting of elevated AVP levels and a con-
centrated urine, these fluids may lower the [Na+]153 or delay
recovery.91,151,154
Although there is no compelling reason to actively treat
asymptomatic EAH, it is clinically appropriate to administer
oral hypertonic saline solutions (HTS), to reduce the risk of
progression to symptomatic hyponatremia139,155; this is par-
ticularly relevant for those with a [Na+] ,130 mmol/L. Upon
departure from the event site, athletes with asymptomatic
EAH should be advised to seek urgent medical attention if
any neurologic signs or symptoms of EAH develop within 24
hours after event finish, since delayed-onset symptomatic
EAH may frequently occur.40,42,46,52,72,80,82,91,100,122,156 Ideally,
an athlete with asymptomatic EAH should have a companion
upon discharge from the medical area to observe the affected
athlete for signs and symptoms of evolving EAH, since the
neurological impairments associated with EAH may limit the
athlete’s ability to accurately self-assess his or her status.
TABLE 5. Signs and Symptoms of Mild and Severe (Life-
threatening) EAH. Signs and Symptoms Related to Other
Conditions Associated With Exercise-Associated Collapse
Noted With an Asterisk (*)





Body weight gain from baseline
Symptoms and Signs Associated With Severe EAH and EAHE
Vomiting*
Headache*
Altered mental status* (confusion, disorientation, agitation, delirium, feelings




Signs of impending brain herniation (decorticate posturing, mydriasis)
Dyspnea (non-cardiogenic pulmonary edema)
Frothy sputum (non-cardiogenic pulmonary edema)
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SUMMARY STATEMENT
The major clinical relevance of asymptomatic EAH lies
in its potential for asymptomatic athletes to quickly transition
and progress into symptomatic stages if hypotonic fluids are
given intravenously or ingested (Grade 1C). Thus, in patients
identified with EAH, hypotonic or isotonic fluids should be
withheld until urination is documented (Grade 1C).
Onsite Treatment of Symptomatic EAH Found
Via [Na+] Measurement
Severe EAH (EAHE)
Acute severely symptomatic hyponatremia is a rapidly
progressing, life threatening emergency that requires imme-
diate administration of IV hypertonic saline (HTS) (such as
3% sodium chloride).38,42,49,51,62,72,82,91 Because EAH is an
acute rather than chronic process, athletes presenting with
symptomatic hyponatremia can and should be treated with
HTS as there is no risk of osmotic demyelination after
exposure to HTS, but there is grave risk of brain herniation
and non-cardiogenic pulmonary edema if HTS is not
administered.5,6,38,47,50,62
Any athlete with EAH associated with signs or
symptoms of encephalopathy should be immediately treated
with an IV bolus or infusion of HTS to acutely reduce brain
edema, with additional IV boluses administered until there is
clinical improvement42,51,72 (Table 6). The dose and route of
HTS administration should be based upon the severity of
clinical symptoms and the available HTS formulations, as
discussed in Table 6. Numerous case reports and case series
have validated the efficacy and safety use of IV HTS admin-
istration in symptomatic EAH8,38,48,49,52,62,72,82,91,100,122,154 with
one runner receiving 950 mL of 3% over a 7-hour period
without complications42 and another swimmer receiving 40
mL of 20% HTS51 without complication.
In the event that an athlete presents with symptoms of
severe, life-threatening encephalopathy (eg, seizures, coma,
or signs of impending brain herniation) it is acceptable and
highly recommended to administer the first bolus of HTS
before [Na+] is measured. Confirmed symptomatic dilutional
(euvolemic or hypervolemic) EAH is a contraindication to the
administration of IV hypotonic fluids, lactated Ringer’s, or
isotonic (normal) saline, all of which can worsen the degree
of hyponatremia41,47,50,134 or delay recovery.91,118,122,151,154,157
The efficacy of IV HTS as the definitive treatment of
acute hyponatremic encephalopathy has been validated
extensively in both hospital and field settings since it was
first utilized successfully in 1938.158 This treatment is based
on the capacity of an IV HTS bolus to increase the serum
[Na+] 2 to 5 mmol/L, resulting in a concomitant decrease of
intracranial pressure and improvement in symptoms.5,6 This
approach does not pose any substantial danger to the patient,
because osmotic demyelination syndrome has not been asso-
ciated with either the rapid correction of acute hyponatremia
(ie, ,48 hours duration) in clinical159 or exercise set-
tings8,38,48,49,52,62,72,82,91,100,122,154 or with the limited increase
in [Na+] produced by a single bolus of HT.139,160 Also, of
note, if the athlete was wrongly assumed to have EAHE,
the administration of HTS in small boluses is not associated
with any negative consequences and serves as an excellent
volume expander.139
The goal of this therapy is to stabilize the athlete for
transfer to an advanced medical care facility for further
evaluation, monitoring and treatment. Ideally, the athlete
should be transported with knowledgeable event medical
personnel able to maintain the same level of care en route
and to ensure that the treatment is not interrupted for
evaluation such as computerized tomography (CT) imaging
of the brain or treatments that may worsen hyponatremia,
such as administration of hypotonic fluids, lactated Ring-
er’s, or isotonic (normal) saline. The diagnosis of EAH or
EAHE must be communicated to the receiving physician
upon transfer of care.
SUMMARY STATEMENT
For those athletes presenting with signs and symptoms
consistent with EAHE, emergent intravenous treatment
therapy with hypertonic saline is indicated and should not
be delayed pending laboratory measurement or other diag-
nostic testing (Grade 1B).
Mild EAH
Any athlete with mild EAH symptoms (Table 6) may
be treated with an IV bolus of HTS as described above.
Alternatively, a mildly symptomatic athlete may be treated
with oral hypertonic solutions when tolerated139,155,160
(Table 6) or observation until urination, as seen in clinical
settings.6,120 Oral sodium tablets may not be as efficacious as
hypertonic solutions, as suggested in a single case report124
and requires further investigation. The efficacy and tolerance
of oral HTS has been supported by limited field
TABLE 6. Recommended Treatment for Both Mild and Severe
(Life-threatening) Symptomatic EAH in Field or in the Hospital
Treatment of Mild EAH
Observation (restrict hypotonic and isotonic fluids until urinating freely)
Administration of intravenous HTS (see below for severe symptomatology)
Administration of oral HTS:
Concentrated bouillon (4 bouillon cubes in 125 mL, ½ cup, of water)
3% NaCl (100 mL), preferably with the addition of a flavoring (eg, Crystal
Light, Kool Aid)
Equivalent volumes of other solutions of high sodium concentration
(eg, 3%-9%)
Treatment of Severe EAH
Administration of intravenous HTS:
100 mL bolus of 3% NaCl, repeated twice if there is no clinical
improvement (10 min intervals have been recommended, but this should
be determined by the clinical judgment of the treating physician)
Comparable amounts of more concentrated Na+-containing solutions
(eg, 10 mL of 20% NaCl; 50 mL of 8.4% NaHCO3) may be used as an
alternative to 3% NaCl
In some situations (ie, more severe encephalopathic symptomatology such
as seizures, coma or signs of impending brain herniation) it may be
appropriate to administer larger HTS boluses initially rather than waiting
to assess clinical improvement after repeated smaller boluses
HTS, hypertonic saline.
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studies,139,155 and may offer practical advantages in some
settings (eg, IV HTS or IV access is not available). In con-
trast to athletes with severe EAH, those with mild symptoms
may be discharged from onsite medical care once symptoms
have resolved and spontaneous urination has occurred.
Repeat measurement of [Na+] is generally not required
unless the patient has persistent symptoms after the initial
treatment. As is recommended for asymptomatic EAH, upon
departure from the event site athletes should be advised to
seek urgent medical attention if any signs or symptoms of
EAH develop after discharge and ideally should have a com-
panion capable of monitoring for signs and symptoms of
which the athlete may not be aware.
SUMMARY STATEMENT
Athletes presenting with mild symptoms associated with
EAH can be treated with an IV bolus of HTS (Grade 1B), oral
hypertonic saline fluids or observation until the onset of
urination as dictated by clinical symptoms (Grade 2B).
Onsite Treatment of EAH Suspected Clinically
but Unable to Confirm Via [Na+]
Measurement
The situation may arise where EAH is strongly
suspected based on the clinical evaluation of the athlete
(ie, history and physical examination showing neurological
symptoms or signs of EAH; Table 3) but [Na+] cannot be
determined,72 such as in a remote setting.39,118,151 In this
situation empiric treatment is justified using the same treat-
ment recommendations described above for EAH docu-
mented with a [Na+] (Table 6). This empiric approach
can be lifesaving and is unlikely to do harm, since: (1)
the additional small increase in serum osmolality from
a single bolus of HTS will not significantly worsen the
neurological status and (2) a bolus of HTS will expand
the intravascular volume by increasing the serum [Na+],
partially reducing any hypovolemic component of the
hyponatremia.139
In Hospital Treatment of Symptomatic EAH
Athletes presenting to a hospital or medical facility,
whether primarily or as a transfer from the event site, with
signs or symptoms of hyponatremia will require immediate
measurement of electrolytes and should be treated as
described above without delay once EAH is confirmed
(Table 6). If symptomatic EAH persists or worsens follow-
ing the initial intervention with IV HTS, current treatment
guidelines for acute symptomatic hyponatremia should be
instituted and the patient managed in an intensive or critical
care setting with care provided or guided by a specialist
familiar with this life threatening condition.5,6
SUMMARY STATEMENT
Athletes presenting to a medical facility with EAH
should be treated as per other settings (Grade 1C). However,
diagnostic testing in these scenarios should not delay
potentially life-saving therapy with HTS (Grade 1C).
Prevention
Athletes and support crews need to carefully consider
fluid and electrolyte supplementation during and after
exercise and the rationale behind those decisions. Excessive
fluid replacement beyond thirst (whether water, sports drinks
or other hypotonic fluids) is not a panacea for all instances of
fatigue, collapse, muscle cramping, or exertional heat stroke
(Table 7). The drinking of fluid volumes sufficiently above
sweat and urinary losses before, during and after activity and
the accrual a positive water balance, is the primary underly-
ing pathophysiological mechanism of symptomatic and fatal
EAH cases.34,41,45,52,57,58,61,71,73,75,76,84,119,122–126,162,163 There-
fore, prevention strategies must target drinking behavior.
Fluid intake recommendations suggesting that athletes begin
to drink fluids before the onset of the sensation of thirst were
targeting those exercising in situations where high sweat
rates were present and dehydration could evolve rapidly
with known medical and performance outcomes. Unfortu-
nately, this advice fostered the misconception that thirst is
a poor guide to fluid replacement in lower sweat rate situa-
tions. We believe that this has facilitated individuals choos-
ing to inadvertently adopt overdrinking and develop
pathologic dilutional EAH, as demonstrated in 41 cases
evaluated in Table 7.
Modest to moderate levels of dehydration are tolerable
and pose little risk to life in otherwise healthy individuals.
Laboratory and field studies indicate that fluid deficits less
than and up to a volume approximately equal to 3% of normal
body mass (or ;5% total body water) can be tolerated with-
out a reduction in endurance performance or muscular power
when in cool to temperate (2108C-208C) temperatures.164
Therefore, aggressive drinking to prevent dehydration is
unnecessary and carries with it greater risk of developing
symptomatic EAH.
Body weight is a reasonable surrogate measure of
hydration state when measured day to day after sleep165 and
can be used to relatively accurately assess changes in
hydration state accompanying upwards to 1 to 2 hours of
activity. However, it is a very imprecise measure during the
athletic events where EAH is most likely to develop, that is,
multiple hours of sustained activity. This is in large part
due to body mass changes accompanying energy
combustion128 and unknown amounts of food consumed,
bathroom stops, etc. Moreover, consolidation of 4 studies
(786 athletes) comparing body weight changes taken at
registration (1-3 days prior) and again within 60 minutes
of race start demonstrate an average 1% increase in body
weight9,10,12,166 from registration to race start. However,
this average value conceals that fact that large gains in
weight (up to at least 4% of body mass)166,167 occur in some
individuals while substantial weight losses occur in others
over that last day or 2 before competition. This weight
increase further confounds the accuracy of bodyweight as
a proxy measure of body water in field events. With
that said, a body mass measured after several hours of
activity that is equal to or above the individuals normal
body mass is a positive indicator for the presence of fluid
overload.
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The safest individualized hydration strategy before,
during and immediately following exercise is to drink
palatable fluids when thirsty (Figure). Marathon runners
with hypernatremia report “thirstiness” as a physiologically
expected symptom149 while a weak but statistically signif-
icant relationship has been demonstrated between thirst rat-
ings and plasma [Na+] immediately following a 161 km
race.168 Studies verify that participants allowed free access
TABLE 7. Thirteen Studies Representing 41 Cases of Symptomatic EAH Which Provided Comment on Drinking Plan or Motivation
for Chosen Drinking Behaviors [*Case Reports Involving Multiple Subjects: Total Number Subjects (Number of Female/Male
Subjects)]
Study




Symptomatic EAH With Drinking Above Thirst
(Comments From Report)
Frizzell et al122 24, ♂/45, ♂, Ultra-runners 123/118 Runners as a group are taught to “push fluids”
Athletes are instructed to drink more than their thirst
dictates
Armstrong et al84 21, ♂, Lab subject 122 .voluntarily consumed this large volume of fluid
because he believed that drinking water copiously
would decrease his risk of heat illness
Herfel et al41 22, ♂, Football player 121 He was diagnosed with muscle cramps secondary to
dehydration. Therefore, five liters (L) of 0.45%
normal saline in 5% dextrose was administered
intravenously along with 3L of liquids by mouth over
a five hour period
Reynolds et al161 *6 (4♀/2♂), Soldiers 118-134 .consuming large volumes of water as “protection
against becoming a heat casualty” predisposed these
troops to the physical impairment that they intended to
avoid
Backer et al73 *7 (6♀/1♂), Hikers 109-127 Most patients diagnosed as having hyponatremia have
a distinct history of high fluid intake.
.unlike heat exhaustion patients, few of our
hyponatremic patients were thirsty when evaluated,
perhaps because they drank more fluids and were
hyperhydrated
Garigan and Ristedt45 18, ♂, Soldier 121 .complained of thirst, drank 3 quarts then
vomited.told to drink 1 quart every 30 minutes.
With encouragement by unit members, he consumed
10 quarts of water during the next 90 minutes
.with encouragement by unit members
Hew et al61 *21 (9♀/8♂), Marathon runners 117-134 Advice given to runners was “drink until your urine is
clear” and “do not wait until you are thirsty to drink”
Dimeff40 27, ♂, Football player 116 .complained of feeling ill. encouraged to consume
sports drinks
.Admits to drinking 2-3 gallons water every day
because he had been taught that “water is the best
replacement fluid” and because that is what he was
advised to do growing up in Texas
Hew-Butler et al8 41, ♂, Ironman triathlete 132 (nadir) Subject reports he was never thirsty, but drank to “stay
ahead of thirst”
Draper et al49 37, ♀, Marathon runner 117 .she followed a strategy (as advised by fellow
experienced marathon runners) to begin the race
“well-hydrated” (drinking greater volumes than her
thirst dictated)
.warnings were issued over the public address system
at the race start relating to ensuring a high intake of
fluids was maintained
Rothwell and Rosengren118 43, ♂, Hiker 107 .complained of abdominal pains and leg cramps for 24
hours leading up to collapse
.on the evening before and day of collapse, fellow
trekkers and guides encouraged him to drink large
amounts of water
Coler et al151 85, ♂, Hiker 120 Subject was encouraged to.“Push fluids” above thirst
Rogers et al51 46, ♀, Swimmer 118 Her intended fluid regimen.was 200mL of fluid every
20 minutes
She reported no sensation of thirst throughout the race
.although she did not feel thirsty, she was encouraged
to drink by the support staff
Hew-Butler et al Clin J Sport Med  Volume 25, Number 4, July 2015
312 | www.cjsportmed.com Copyright © 2015 retained by authors Hew Butler T et al. All rights reserved.
to fluids during treadmill walking in the heat169 or running
30 km under different ambient conditions170 maintain
plasma osmolality by drinking to thirst. Moreover, the cues
to drink provided by osmolality and blood volume persist in
both hot101 and cold171 environments. Thus, drinking to
thirst will, in most cases, prevent both dilutional EAH and
performance decrements due to excessive dehydration.10
Potential exceptions to this fluid replacement strategy
are thirst stimulated by confounding oral variables such
as dry mouth (xerostomia),102,172 genetic influences,103
FIGURE. Primary recommended
fluid intake strategy to prevent
symptomatic EAH.
TABLE 8. Four Case Reports Reporting Symptomatic EAH While Drinking Either ad libitum (First 2 Cases) or in Response to Thirst
(Second 2 Cases)
Study
Subjects Age (yo), Sex (♂♀),
Activity Plasma [Na+] mmol/L (Initial)
Symptomatic EAH With ad libitum Drinking (Comments
From Report)
Baker et al85 65, ♀, Lab trial 126 46kg♀ drank 2.8L water and gained 2.4 kg in 2.5 hr intermittent
cycling trial 308C
Subjects were not encouraged to drink but told that more fluid
was readily available if needed
Hew-Butler134 28, ♀, cyclist 114 Subject followed her normal practice of ingesting a GU packet
with 200mL of water every
45 minutes with Coke and water ad libitum for an estimated
fluid consumption rate of ;550ml/hr
Study




Symptomatic EAH With Drinking in Response to Thirst
(Comments From Report)
Khodaee et al100 44, ♂, Mountain biker 116 84kg♂ drank 29L water and 5.3 g sodium during plus after race
(;14 hrs total)
History of muscle cramping after 5-6hr cycling. Felt “very
thirsty” after the race
Initial labwork in hospital: urine[Na+] = 31 mmol/L and BUN =
19 mg/dl
Labwork 2 months after hospitalization: plasma [Na+] = 133
mmol/L, BUN = 10 mg/dl
Hoffman et al72 53, ♂, Ultra-runner 122 Subject began using “regular sodium supplementation” and
“very thirsty” at 100km
2.2% weight gain noted at 126km and dropped out of race at
145km (28 hrs)
Initial labwork in hospital: BUN = 22 mg/dl
17 hrs later in hospital (.10.4L 0.9% saline), plasma [Na+] =
136 mmol/L and BUN = 10 mg/dl
Subject received 20L of IV fluids in hospital and discharged
with positive fluid balance of 6.6L
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known discrepancies between drinking “ad libitum” versus
drinking according to the dictates of thirst,173 excessive
sodium intake and/or other non-osmotic or hypovolemic
factors that are yet to be determined and require further
investigation (Table 8).72,100
SUMMARY STATEMENT
Given that excessive fluid consumption is a primary
etiologic factor in EAH, using the innate thirst mechanism to
guide fluid consumption is a strategy that should limit drinking
in excess and developing hyponatremia while providing
sufficient fluid to prevent excessive dehydration (Grade 1C).
Additional Strategies to Prevent EAH
Sodium Supplementation
When fluid intake matches or even slightly exceeds
sweat losses, the ingestion of sodium-containing sports drinks
can attenuate the rate of fall of [Na+] over the course of 2
hours of continuous174 or intermittent85 cycling and ;4 hours
of running.89,175 However, it is critical to emphasize that
sodium containing sports drinks, which are hypotonic, will
not prevent EAH in athletes who overdrink during exercise,
as all sports drinks have a significantly lower [Na+] (10-38
mmol/L) than serum (;140 mmol/L). The dilutional effect of
volume excess overwhelms any positive effect of sodium and
electrolytes in sports drinks.90 Therefore, while modest salt
replacement is likely not harmful and has been associated
with significant increases176 or no change14,177 in serum
[Na+] during competitive field events it will be of modest to
no benefit in situations where excess fluids are being con-
sumed. The potential detrimental effects of excessive sodium
supplementation are not clear.72,178
SUMMARY STATEMENT
Sodium supplementation is a strategy for attenuating
sodium concentration reductions that can develop when fluid
intakes approximate sweat losses during prolonged exercise
but cannot prevent EAH in the setting of a persistent excessive
fluid intake that produces fluid overload (Grade 1C).
Education and Event Management Efforts
Athlete and support team educational strategies should
be instituted to improve knowledge of safe hydration
practices and reduce the overemphasis on high fluid intakes.
For example, an education program for an Ironman triathlon
advising athletes of the risks incurred by overdrinking
coupled with decreasing the number of fluid stations
to limit the fluid availability reduced the incidence of
EAH.179–181 Dissemination of appropriate drinking advice
alone has also been shown to reduce the incidence of
EAH in a 90 km footrace.150,182
Past studies have demonstrated that cycling fluid
stations placed 20 km apart in an Ironman triathlon and
running fluid stations placed 5 km apart in a standard
marathon have reduced or prevented EAH.53,180 However,
this proposed strategy and its effect on the incidence of
EAH needs further study to determine the optimal number
and spacing of fluid stations in different terrains and ambient
temperatures. Furthermore, alternative strategies will be
needed in settings where EAH has been noted but either aid
stations are not provided or in situations where drinks are
freely available and/or athletes transport their own fluids.
Athletes who seek more quantitative guidance are
encouraged to weigh themselves before and after training to
assess their sweating rates and fluid replacement needs. Some
weight loss associated with activity will be unrelated to fluid
status as non-water mass is lost as energy is expended
(;0.23-0.24 g/kcal)128,183 and is increased with increasing
duration and intensity of exercise.128 The presence of weight
gain is positive indicator that fluid intake has been in excess
of fluid losses and water overload is present.
SUMMARY STATEMENT
Educational efforts regarding the risks of overhydra-
tion should be encouraged and disseminated widely to
athletes, coaches, and event management personnel (Grade
1C). These efforts should include all sporting events where
EAH has been encountered. Event management strategies
such as limiting access to fluids may be of benefit, but
require broader study.
Dissemination of Advice for Prevention and
Treatment of EAH
Athletes, Coaches, Parents
Educational strategies and programs are needed that
effectively communicate to coaches, athletes, and parents
rational fluid replacement, avoidance of overconsuming fluids
(water, sports drinks or other hypotonic fluids), to recognize
the signs and symptoms of EAH, and to understand the
critical need for immediate medical attention for suspected
casualties. Athletes, coaches and parents must be alert to the
risks of excessive fluid consumption and understand that high
fluid intakes will not necessarily prevent exercise-associated
maladies such as muscle cramps or exertional heat stroke.
On-site Medical Professionals (Medics, Paramedics,
Emergency Medical Technicians, Athletic Trainers,
Physiotherapists, and Others)
The educational strategies for on-site medical person-
nel must address the circumstances (during or following
events or practices during acclimatization), identification,
evaluation and management of EAH and EAHE, and
emphasize that the life-threatening nature of these rare
conditions require immediate intervention. The pathophys-
iology of EAH and the drinking behaviours involved in the
evolution of EAH must be clearly recognized. It should be
stressed that: (1) EAH is caused primarily by the consump-
tion of hypotonic fluid in excess of sweat and urinary losses
and (2) excessive fluid intake (water, sports drinks or other
hypotonic beverages) may not prevent muscle cramps or
exertional heatstroke and in rare cases may even be
associative.82,100,118–120,184 On-site personnel must under-
stand that oral fluid intake and IV fluid infusion of hypotonic
and isotonic fluids is contraindicated in all suspected cases
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of EAH and rapid transfer to a hospital is necessary. The
potential life-saving role of HTS requires wide-spread edu-
cation and should be considered the equivalent of automatic
external defibrillators and ice/cold water immersion in the
“first aid” of sudden cardiac arrest and exertional heat
stroke, respectively.
Team Physicians and Medical Directors of
Athletic Events
Team physicians and medical directors of athletic
events should be involved in all decisions regarding medical
management including overseeing medical protocols, med-
ical supplies/equipment, strategies for fluid replacement that
optimize safe hydration practices, placement of fluid sta-
tions, and the use of intravenous rehydration. Important
athletic event decisions include spacing and placement of
fluid stations, distribution of fluid replacement advice to
athletes, and training of the aid station personnel and
spectators. Drinking advice distributed to participants by
sponsors should be reviewed by and approved by the event
medical team to avoid conflict with the official race
educational information.
Team physicians and event medical directors should
ideally have onsite point of care [Na+] analysis available and
hypertonic saline on hand for management of EAH and
EAHE. The event organizer/medical director should be in
contact with the local emergency medical services to ensure
that transportation to an advanced care medical facility is
available during events with high risk for EAH (Table 2).
A record of EAH cases should be kept, including follow
up and outcome, to aid in planning for future events and to
establish both incidence and prevalence for different events.
Emergency Medical Services and Hospitals
Prior to the race or athletic event, the medical team
should establish a relationship with the local emergency
response and transport teams, medical facilities and emer-
gency department physicians. This may include specific
collaborative education programs aimed at all of these groups
and pre-event checklists to ensure that the appropriate course
of action is taken and the needed supplies are available in the
emergency room when an athlete arrives in extremis.
SUMMARY STATEMENT
Prevention of EAH requires broad educational pro-
grams with consistent messages that stress the importance of
appropriate hydration practices, recognition of EAH and
proper therapy (Grade 1C).
Controversies in EAH
Hypovolemic Hyponatremia
It is unclear whether the hypovolemic variant of EAH
has medical consequences. At present, we have apparent
evidence of hypovolemic hyponatremia developing over the
course of ultra-endurance event, but we lack data regarding: (1)
the relative contribution of solute deficits versus fluid status
and (2) whether or not the hypovolemic component is
somehow compromising the afflicted individual. Most of the
contributions of sweat and urinary sodium losses are negligible
to the overall pathogenesis of EAH with the possible exception
of volume depleted athletes with low serum sodium levels.
Thermoregulatory sweat is hypotonic, with sweat sodium
concentrations ranging between 10 and 70 mmol/L,164 which
are well below the normal (isotonic) range of values for serum
[Na+] (135-145 mmol/L). While there will always be some
contribution of sodium loss to the pathogenesis of EAH—
which will vary significantly in magnitude depending on: exer-
cise intensity, exercise duration, body size, and relative
ambient temperature185–187—it is not clear whether or not sweat
sodium losses alone can account for the changes in hypovole-
mic hyponatremia in athletes. The potential role of urinary
sodium losses from exercise-induced brain natriuretic peptide
secretion contributing to EAH is also unclear.16,188
There are 3 distinct groups of athletes that demonstrate
extreme sodium conservation which may increase the sus-
ceptibility towards the development of hypovolemic hypona-
tremia: (1) runners participating in 161 km races under hot
conditions139; (2) Ironman triathletes participating in hot and
humid Ironman triathlons19,20 and (3) football players during
the first week of training camp.189 These 3 groups would
hypothetically be at greater risk for developing the hypovo-
lemic variant of EAH from more vigorous and sustained
sweating (and associated sweat sodium and potassium losses)
coupled with an inability to eat sufficient foods to offset the
sodium and potassium losses. Football players may also lack
adequate adaptations to heat stress, at the onset of pre-season
training, which would prevent excessive sweat sodium losses
with repeated exposure.
Treatment of Hypovolemic Hyponatremia
Participants with suspected hypovolemic EAH and
developing signs of encephalopathy would be best treated
initially with an IV HTS bolus to reverse intracerebral edema
and expand the intravascular volume. The initial bolus of
HTS can be followed by IV 0.9% saline, if neurological
symptoms improve. At least one panel member has success-
fully treated athletes who were clinically volume depleted,
with measures of [Na+] as low as 124 mmol/L, with IV nor-
mal saline infusion. As in all cases of EAH, it would be
harmful to treat with hypotonic IV solutions.
Clinical Importance of Asymptomatic EAH
The clinical relevance of the asymptomatic form of
EAH continues to be disputed. We agree that the main clinical
relevance of asymptomatic EAH lays in the potential for
asymptomatic athletes to transition to symptomatic EAH with
the continued ingestion of hypotonic fluids.36,120 Moreover,
symptomatic EAH can rapidly progress to life-threatening
symptomatic hyponatremia if large volumes of hypotonic
fluids are ingested after identification of asymptomatic EAH
is present82 or are administered intravenously134 during recov-
ery from exercise.
SUGGESTIONS FOR FUTURE RESEARCH
Prospective and controlled clinical trials should be
performed both in the laboratory and in the field to best
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determine optimal preventative and therapeutic strategies.
Some of the remaining issues for study include:
• Examining nutritional requirements and/or role of diet on
the risk for EAH.
• Examining tolerance versus risk for various forms (tablets
vs solution) and amounts of sodium supplementation on
health, performance and natremia status.
• Gathering evidence with regards to the success of the
“drink to thirst” strategy on prevention and/or reduction
of the incidence of EAH in athletic events.
• Determining if the development of EAH increases the risk
for recurrence and/or long-term health problems.
• Identifying genetic markers which may predispose individ-
uals to developing EAH.
• Additional research is necessary to understand whether in-
dividuals consuming NSAIDS are at heightened risk of
developing EAH.
• Investigating the efficacy of alternative treatments for non-
life threatening EAH, including oral hypertonic sodium sol-
utions, sodium tablets and vasopressin receptor antagonists.
• Clarifying the etiology behind the apparent hypovolemic
variant of EAH and the potential for pathophysiological
consequences.
• Evaluating the variability in [Na+] in the days leading up to
the event, at event start and during the event.
• Evaluating the variability in body weight in the days lead-
ing up to the event and at event start.
SUMMARY OF RECOMMENDATIONS
Etiology of EAH
1. The primary etiology and pathophysiological mechanism
underlying EAH—and all known fatalities—is the over-
consumption of hypotonic fluids relative to exchangeable
sodium in likely combination with non-osmotic AVP
secretion (Grade 1A).
2. Under-replaced sodium losses contribute to serum [Na+]
independent of distance (Grade 1A). However, there is
paucity of data supporting sodium loss as the primary
mechanism of symptomatic EAH even in those who exer-
cise for prolonged periods of time and in warm weather
(Grade 2C). In these cases, relative over-drinking of hypo-
tonic fluids with sustained non-osmotic AVP secretion is
likely involved in the development of symptomatic EAH.
Clinical Classification and Diagnosis of EAH
1. EAH can present with a wide range of symptoms ranging
from nonspecific mild complaints to severe encephalopa-
thy. The severity of symptoms and not the absolute value
of the [Na+] should guide the choice of therapy (Grade
1A). Rapid determination of [Na+] is critical in confirming
clinical suspicion but may not always be available.
Treatment of EAH
1. The major clinical relevance of asymptomatic EAH lies in is
its potential for asymptomatic athletes to quickly transition
progression into symptomatic stages if hypotonic fluids are
given intravenously or ingested (Grade 1C). Thus, in patients
identified with EAH, hypotonic or isotonic fluids should be
withheld until urination is documented (Grade 1C).
2. For those athletes presenting with signs and symptoms
consistent with EAHE, emergent intravenous treatment
therapy with hypertonic saline is indicated and should
not be delayed pending laboratory measurement or other
diagnostic testing (Grade 1B).
3. Athletes presenting with mild symptoms associated with
EAH can be treated with an IV bolus of HTS (Grade 1B),
oral hypertonic saline fluids or observation until the onset
of urination as dictated by clinical symptoms (Grade 2B).
4. Athletes presenting to a medical facility with EAH should
be treated as per other settings (Grade 1C). However,
diagnostic testing in these scenarios should not delay
potentially life-saving therapy with HTS (Grade 1C).
Prevention of EAH
1. Given that excessive fluid consumption is a primary etio-
logic factor in EAH, using the innate thirst mechanism to
guide fluid consumption is a strategy that should limit
drinking in excess and developing hyponatremia while
providing sufficient fluid to prevent excessive dehydration
(Grade 1C).
2. Prevention of EAH requires broad educational programs
with consistent messages that stress the importance of
appropriate hydration practices, recognition of EAH and
proper therapy (Grade 1C).
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